Today’s top gainers include the company Biogen Inc. (NASDAQ:BIIB) which is in the industry Biotechnology, gaining 0.00% today. In the last week its performance is -0.84%, and -8.58% for the past quarter. Currently, Biogen Inc., BIIB has a target price of 318.59, so today’s gain of 0.00% is a significant step towards its target price. The GAP today is therefore 0.00%.
Biogen Inc. (NASDAQ:BIIB), has a market cap of 54.98 B, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 90.50%.
At the current price of 255.02, it has a dividend yield of *TBA, and its target price is 318.59. This is with a profit margin of 30.20%, and total debt/equity of 0.57. Biogen Inc. (NASDAQ:BIIB) has a P/E of 15.99, as well as a forward P/E of 11.33.
With a current EPS of 15.95, and a forecasted EPS growth for next year at 9.90%,Biogen Inc. (NASDAQ:BIIB) has had a EPS growth for the past five years at 27.40%. For the next five years EPS growth is projected to be 6.34%.
Performance for the year is 15.89%. Since its IPO date on 9/17/1991, the total performance to date is -2.37%.
Volume today for Biogen Inc. (NASDAQ:BIIB), is 0, while its average volume is 1618.31. Whilst the total gain today was 0.00%, it did have a day high of -12.63%.
Volatility for this week has been at 1.97%, and 1.70% for the month. The 52-week low for Biogen Inc., BIIB has been 24.14%, while the 52-week-high has reached -17.02%.
Looking at its return of investments, which is 21.00%, and its return on assets is 15.90%. Biogen Inc. (NASDAQ:BIIB) has an operating margin of 41.60%. With a sales growth of 3.10% quarter over quarter. Bearing in mind that Biogen Inc., BIIB is in the sector Healthcare, its long-term debt/equity is 0.52, and has a current ratio of 2.3 and 2 for quick ratio.
So what is the value of Biogen Inc.? Well its PEG is 2.52, and the P/S is 4.77, along with a P/B of 4.79. Meanwhile it has a p/cash of 19.09.